MERRIMACK PHARMACEUTICALS INC Research and Development Expense
MERRIMACK PHARMACEUTICALS INC reported Research and Development Expense of $11.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-03-10
- MERRIMACK PHARMACEUTICALS INC research and development expense for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- MERRIMACK PHARMACEUTICALS INC research and development expense for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- MERRIMACK PHARMACEUTICALS INC research and development expense for the quarter ending 2019-06-30 was $4.74M, a 65.35% decline year-over-year.
- MERRIMACK PHARMACEUTICALS INC research and development expense for the quarter ending 2019-03-31 was $6.36M, a 51.46% decline year-over-year.
- MERRIMACK PHARMACEUTICALS INC research and development expense for fiscal 2019 was $11.10M, a 77.79% decline from fiscal 2018.
- MERRIMACK PHARMACEUTICALS INC research and development expense for fiscal 2018 was $49.97M, a 25.76% decline from fiscal 2017.
- MERRIMACK PHARMACEUTICALS INC research and development expense for fiscal 2017 was $67.31M, a 38.56% decline from fiscal 2016.
- MERRIMACK PHARMACEUTICALS INC research and development expense for fiscal 2016 was $109.56M, a 9.48% decline from fiscal 2015.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 derived: sum of 2 quarters · filed 2021-03-10 | $4.74M derived: sum of 3 quarters · filed 2021-03-10 | $11.10M 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $4.74M derived: sum of 2 quarters · filed 2020-11-04 | $11.10M 10-Q · filed 2020-11-04 | $21.33M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $4.74M 10-Q · filed 2020-08-07 | $11.10M 10-Q · filed 2020-08-07 | $21.33M derived: sum of 3 quarters · filed 2020-08-07 | $34.29M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $6.36M 10-Q · filed 2020-05-07 | $16.59M derived: sum of 2 quarters · filed 2020-05-07 | $29.55M derived: sum of 3 quarters · filed 2020-05-07 | $43.23M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $10.23M 10-K · filed 2019-03-06 | $23.19M derived: sum of 2 quarters · filed 2019-11-12 | $36.87M derived: sum of 3 quarters · filed 2019-11-12 | $49.97M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $12.96M 10-Q · filed 2019-11-12 | $26.64M derived: sum of 2 quarters · filed 2019-11-12 | $39.74M 10-Q · filed 2019-11-12 | $52.10M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $13.68M 10-Q · filed 2019-07-17 | $26.78M 10-Q · filed 2019-07-17 | $39.14M derived: sum of 3 quarters · filed 2019-07-17 | $52.74M derived: sum of 4 quarters · filed 2019-07-17 | ||||
| 2018-03-31 | $13.11M 10-Q · filed 2019-05-10 | $25.47M derived: sum of 2 quarters · filed 2019-05-10 | $39.06M derived: sum of 3 quarters · filed 2019-05-10 | $58.81M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $12.36M 10-K · filed 2019-03-06 | $25.96M derived: sum of 2 quarters · filed 2019-03-06 | $45.71M derived: sum of 3 quarters · filed 2019-03-06 | $67.31M 10-K · filed 2019-03-06 | ||||
| 2017-09-30 | $13.60M 10-K · filed 2019-03-06 | $33.35M derived: sum of 2 quarters · filed 2019-03-06 | $54.95M 10-Q · filed 2018-11-07 | $80.58M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-06-30 | $19.75M 10-K · filed 2019-03-06 | $41.36M 10-Q · filed 2018-08-07 | $66.98M derived: sum of 3 quarters · filed 2019-03-06 | $95.22M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2017-03-31 | $21.61M 10-K · filed 2019-03-06 | $47.23M derived: sum of 2 quarters · filed 2019-03-06 | $75.47M derived: sum of 3 quarters · filed 2019-03-06 | $103.17M derived: sum of 4 quarters · filed 2019-03-06 | ||||
| 2016-12-31 | $25.62M 10-K · filed 2018-03-12 | $54.96M 10-K · filed 2017-03-01 | $53.87M derived: sum of 2 quarters · filed 2018-03-12 | $81.56M derived: sum of 3 quarters · filed 2018-03-12 | $109.56M 10-K · filed 2018-03-12 | $160.92M 10-K · filed 2017-03-01 | ||
| 2016-09-30 | $28.25M 10-K · filed 2018-03-12 | $32.08M 10-Q · filed 2016-11-09 | $55.94M derived: sum of 2 quarters · filed 2018-03-12 | $83.94M 10-Q · filed 2017-11-08 | $105.96M 10-Q · filed 2016-11-09 | $122.12M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $27.70M 10-K · filed 2018-03-12 | $41.00M 10-Q · filed 2016-08-04 | $55.70M 10-Q · filed 2017-08-09 | $73.88M 10-Q · filed 2016-08-04 | $93.87M derived: sum of 3 quarters · filed 2018-03-12 | $123.82M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-03-31 | $28.00M 10-K · filed 2018-03-12 | $32.88M 10-Q · filed 2016-05-02 | $66.18M derived: sum of 2 quarters · filed 2018-03-12 | $96.12M derived: sum of 3 quarters · filed 2018-03-12 | $122.60M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $38.17M 8-K · filed 2017-12-15 | $44.74M 10-K · filed 2016-02-26 | $68.12M derived: sum of 2 quarters · filed 2017-12-15 | $94.60M derived: sum of 3 quarters · filed 2017-12-15 | $121.03M 10-K · filed 2018-03-12 | $160.99M 10-K · filed 2016-02-26 | ||
| 2015-09-30 | $29.94M 8-K · filed 2017-12-15 | $37.76M 10-Q · filed 2015-11-09 | $56.42M derived: sum of 2 quarters · filed 2017-12-15 | $116.25M 10-Q · filed 2016-11-09 | $113.60M derived: sum of 4 quarters · filed 2017-12-15 | |||
| 2015-06-30 | $26.48M 8-K · filed 2017-12-15 | $42.81M 10-Q · filed 2015-08-10 | $78.48M 10-Q · filed 2016-08-04 | $83.66M derived: sum of 3 quarters · filed 2017-12-15 | $127.29M derived: sum of 4 quarters · filed 2017-12-15 | |||
| 2015-03-31 | $26.43M 8-K · filed 2017-12-15 | $35.68M 10-Q · filed 2015-05-07 | $57.18M derived: sum of 2 quarters · filed 2017-12-15 | $100.81M derived: sum of 3 quarters · filed 2017-12-15 | $134.61M derived: sum of 4 quarters · filed 2017-12-15 | |||
| 2014-12-31 | $30.74M 10-K · filed 2016-02-26 | $74.38M derived: sum of 2 quarters · filed 2016-02-26 | $108.17M derived: sum of 3 quarters · filed 2016-02-26 | $103.31M 8-K · filed 2017-12-15 | $138.50M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $43.63M 10-K · filed 2016-02-26 | $77.43M derived: sum of 2 quarters · filed 2016-02-26 | $107.75M 10-Q · filed 2015-11-09 | $137.81M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $33.80M 10-K · filed 2016-02-26 | $64.12M 10-Q · filed 2015-08-10 | $94.17M derived: sum of 3 quarters · filed 2016-02-26 | $131.80M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $30.32M 10-K · filed 2016-02-26 | $60.38M derived: sum of 2 quarters · filed 2016-02-26 | $98.01M derived: sum of 3 quarters · filed 2016-02-26 | $140.47M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $30.05M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $67.69M derived: sum of 2 quarters · filed 2016-02-26 | $110.15M derived: sum of 3 quarters · filed 2016-02-26 | $147.14M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $37.63M 10-Q · filed 2014-11-10 | $80.09M derived: sum of 2 quarters · filed 2014-11-10 | $117.08M 10-Q · filed 2014-11-10 | $151.65M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $42.47M 10-Q · filed 2014-08-11 | $79.45M 10-Q · filed 2014-08-11 | $114.02M derived: sum of 3 quarters · filed 2015-02-27 | $144.90M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $36.99M 10-Q · filed 2014-05-06 | $71.55M derived: sum of 2 quarters · filed 2015-02-27 | $102.44M derived: sum of 3 quarters · filed 2015-02-27 | $131.20M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $34.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $65.45M derived: sum of 2 quarters · filed 2015-02-27 | $94.21M derived: sum of 3 quarters · filed 2015-02-27 | $125.86M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $30.89M 10-Q · filed 2013-11-08 | $59.64M derived: sum of 2 quarters · filed 2013-11-08 | $91.29M 10-Q · filed 2013-11-08 | $118.82M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2012-06-30 | $28.76M 10-Q · filed 2013-08-08 | $60.41M 10-Q · filed 2013-08-08 | $87.94M derived: sum of 3 quarters · filed 2014-03-04 | $111.85M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2012-03-31 | $31.65M 10-Q · filed 2013-05-13 | $59.18M derived: sum of 2 quarters · filed 2014-03-04 | $83.09M derived: sum of 3 quarters · filed 2014-03-04 | $114.28M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2011-12-31 | $27.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $51.44M derived: sum of 2 quarters · filed 2014-03-04 | $82.63M derived: sum of 3 quarters · filed 2014-03-04 | $100.63M 10-K · filed 2014-03-04 | ||||
| 2011-09-30 | $23.91M 10-Q · filed 2012-11-14 | $55.10M derived: sum of 2 quarters · filed 2012-11-14 | $73.10M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | $31.19M 10-Q · filed 2012-08-14 | $49.19M 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | $18.00M 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | $58.28M 10-K · filed 2013-03-20 |